EnVVeno Medical Correlations
NVNO Stock | USD 3.53 0.04 1.15% |
The current 90-days correlation between enVVeno Medical Corp and LENSAR Inc is 0.12 (i.e., Average diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as EnVVeno Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if enVVeno Medical Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
EnVVeno Medical Correlation With Market
Average diversification
The correlation between enVVeno Medical Corp and DJI is 0.16 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding enVVeno Medical Corp and DJI in the same portfolio, assuming nothing else is changed.
EnVVeno |
Moving against EnVVeno Stock
0.7 | EXAS | EXACT Sciences | PairCorr |
0.61 | EMBC | Embecta Corp | PairCorr |
0.52 | WST | West Pharmaceutical | PairCorr |
0.43 | ADUS | Addus HomeCare | PairCorr |
0.55 | INZY | Inozyme Pharma | PairCorr |
0.48 | ILMN | Illumina | PairCorr |
0.4 | NAMSW | NewAmsterdam Pharma | PairCorr |
0.37 | ADTX | Aditxt Inc | PairCorr |
0.35 | XFOR | X4 Pharmaceuticals | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between EnVVeno Stock performing well and EnVVeno Medical Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze EnVVeno Medical's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
AZYO | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
AIMD | 5.91 | 0.84 | 0.11 | (0.95) | 6.14 | 17.74 | 74.23 | |||
SRDX | 0.85 | (0.13) | 0.00 | (0.86) | 0.00 | 1.67 | 9.34 | |||
LNSR | 3.07 | 0.44 | 0.13 | 0.58 | 3.09 | 7.49 | 20.58 | |||
IRIX | 2.32 | (0.35) | 0.00 | (0.91) | 0.00 | 6.15 | 17.43 | |||
RXST | 2.14 | (0.63) | 0.00 | (0.79) | 0.00 | 3.73 | 15.79 | |||
AXGN | 2.55 | 0.70 | 0.28 | 1.98 | 2.24 | 5.32 | 21.20 | |||
TMCI | 2.85 | 0.47 | 0.18 | 0.47 | 2.28 | 8.14 | 18.71 | |||
LUNG | 3.19 | 0.76 | 0.26 | (1.03) | 2.57 | 6.22 | 34.92 | |||
OFIX | 1.13 | (0.12) | 0.00 | (0.19) | 0.00 | 2.18 | 6.60 |
EnVVeno Medical Corporate Management
Andrew Cormack | Chief Officer | Profile | |
Craig Glynn | Treasurer CFO | Profile | |
Benedict MD | Chief States | Profile | |
Sandy Prietto | Vice Marketing | Profile | |
Robert Berman | CEO Director | Profile | |
Marc MD | Senior Officer | Profile | |
Hamed Alavi | Senior Officer | Profile |